Cargando…
Long-term use of benzodiazepines in chronic insomnia: a European perspective
Chronic insomnia occurs in ~10% of the general population and has numerous negative health effects. The recommended first line treatment of cognitive behavior therapy for insomnia is not widely available for patients in Europe, so pharmacotherapies such as benzodiazepine receptor agonist agents (ben...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433200/ https://www.ncbi.nlm.nih.gov/pubmed/37599882 http://dx.doi.org/10.3389/fpsyt.2023.1212028 |